価格表
在庫・価格 : 2025年04月26日 07時32分 現在
商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
---|---|---|---|---|---|---|
Anti-Akt1 - Azide and BSA Free (pSer473), Phosphorylated, Mouse-Mono(104A282) |
NBP2-27399SS |
NOVノバス バイオロジカルス Novus biologicals, LLC |
0.025 mg | ¥48,000 |
無 (未発注) |
追加 |
在庫・価格 : 2025年04月26日 07時32分 現在
使用文献
- No.: 1
-
文献情報:
Nair AS et al. Deguelin, an Akt inhibitor, suppresses IkappaBalpha kinase activation leading to suppression of NF-kappaB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion. J. Immunol. 2006 Oct;177(8):5612-22
Nair AS et al
2006/01/01
-
備考:
Applications: -
参照:
- No.: 2
-
文献情報:
Juengel E et al. Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells. BMC Cancer 2009;9:161
Juengel E et al
2009/01/01
-
備考:
Applications: WB -
参照:
- No.: 3
-
文献情報:
Wedel S et al. Inhibitory effects of the HDAC inhibitor valproic acid on prostate cancer growth are enhanced by simultaneous application of the mTOR inhibitor RAD001. Life Sci. 2011 Feb;88(9-10):418-24
Wedel S et al
2011/01/01
-
備考:
Applications: WB -
参照:
- No.: 4
-
文献情報:
Wedel S et al. Critical analysis of simultaneous blockage of histone deacetylase and multiple receptor tyrosine kinase in the treatment of prostate cancer. Prostate 2011 May;71(7):722-35
Wedel S et al
2011/01/01
-
備考:
Applications: WB -
参照: